University Of Nottingham investment portfolio

Alevin Therapeutics is a biotechnology company developing targeted integrin inhibitor medicines for fibrotic diseases, including idiopathic pulmonary fibrosis.

Azotic Technologies develops and commercialises biotechnological products that enable crops to fix atmospheric nitrogen, reducing reliance on synthetic nitrogen fertilizers and improving yields. Its flagship product, Envita (known as Encera in Europe), is marketed to farmers and agricultural producers worldwide.